| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| SLP(L) | 110 | 40.9% | 0.31 | 136 | 50.4% |
| SCL(L) | 47 | 17.5% | 0.17 | 53 | 19.6% |
| PLP(L) | 30 | 11.2% | 0.49 | 42 | 15.6% |
| LH(L) | 31 | 11.5% | -0.43 | 23 | 8.5% |
| PVLP(L) | 31 | 11.5% | -1.95 | 8 | 3.0% |
| AVLP(L) | 18 | 6.7% | -1.36 | 7 | 2.6% |
| CentralBrain-unspecified | 2 | 0.7% | -1.00 | 1 | 0.4% |
| upstream partner | # | NT | conns SLP307 | % In | CV |
|---|---|---|---|---|---|
| LC16 (L) | 13 | ACh | 21 | 8.6% | 0.7 |
| SMP447 (L) | 2 | Glu | 10 | 4.1% | 0.2 |
| LHAV2a3 (L) | 3 | ACh | 10 | 4.1% | 0.3 |
| MBON20 (L) | 1 | GABA | 8 | 3.3% | 0.0 |
| LHAV1f1 (L) | 5 | ACh | 8 | 3.3% | 0.8 |
| M_l2PNl22 (L) | 1 | ACh | 7 | 2.9% | 0.0 |
| LHAV2p1 (L) | 1 | ACh | 7 | 2.9% | 0.0 |
| mALB2 (R) | 1 | GABA | 7 | 2.9% | 0.0 |
| SLP160 (L) | 4 | ACh | 6 | 2.5% | 0.3 |
| LHAV3q1 (L) | 1 | ACh | 5 | 2.0% | 0.0 |
| CL126 (L) | 1 | Glu | 4 | 1.6% | 0.0 |
| LHPV2a1_d (L) | 1 | GABA | 4 | 1.6% | 0.0 |
| SLP438 (L) | 1 | unc | 4 | 1.6% | 0.0 |
| VL2a_vPN (L) | 1 | GABA | 4 | 1.6% | 0.0 |
| LHPV6g1 (L) | 1 | Glu | 4 | 1.6% | 0.0 |
| AN17A062 (L) | 2 | ACh | 4 | 1.6% | 0.5 |
| SLP056 (L) | 1 | GABA | 3 | 1.2% | 0.0 |
| LHAV3g2 (L) | 1 | ACh | 3 | 1.2% | 0.0 |
| SLP080 (L) | 1 | ACh | 3 | 1.2% | 0.0 |
| LHPV6p1 (L) | 1 | Glu | 3 | 1.2% | 0.0 |
| LHPV5b1 (L) | 1 | ACh | 3 | 1.2% | 0.0 |
| AVLP164 (L) | 1 | ACh | 3 | 1.2% | 0.0 |
| LHAD1a2 (L) | 1 | ACh | 3 | 1.2% | 0.0 |
| VES034_b (R) | 1 | GABA | 3 | 1.2% | 0.0 |
| SLP035 (L) | 1 | ACh | 3 | 1.2% | 0.0 |
| VP3+VP1l_ivPN (L) | 1 | ACh | 3 | 1.2% | 0.0 |
| AVLP595 (R) | 1 | ACh | 3 | 1.2% | 0.0 |
| PVLP121 (R) | 1 | ACh | 3 | 1.2% | 0.0 |
| CB2185 (L) | 2 | unc | 3 | 1.2% | 0.3 |
| SMP447 (R) | 2 | Glu | 3 | 1.2% | 0.3 |
| CB3255 (L) | 1 | ACh | 2 | 0.8% | 0.0 |
| CB2786 (L) | 1 | Glu | 2 | 0.8% | 0.0 |
| PVLP121 (L) | 1 | ACh | 2 | 0.8% | 0.0 |
| Z_vPNml1 (L) | 1 | GABA | 2 | 0.8% | 0.0 |
| VES025 (R) | 1 | ACh | 2 | 0.8% | 0.0 |
| CB1103 (L) | 1 | ACh | 2 | 0.8% | 0.0 |
| CL142 (L) | 1 | Glu | 2 | 0.8% | 0.0 |
| LHAV4c1 (L) | 1 | GABA | 2 | 0.8% | 0.0 |
| SLP472 (L) | 1 | ACh | 2 | 0.8% | 0.0 |
| WEDPN10A (R) | 1 | GABA | 2 | 0.8% | 0.0 |
| AVLP189_b (L) | 1 | ACh | 2 | 0.8% | 0.0 |
| VES025 (L) | 1 | ACh | 2 | 0.8% | 0.0 |
| M_imPNl92 (L) | 1 | ACh | 2 | 0.8% | 0.0 |
| LHCENT11 (L) | 1 | ACh | 2 | 0.8% | 0.0 |
| PLP180 (L) | 2 | Glu | 2 | 0.8% | 0.0 |
| LC41 (L) | 2 | ACh | 2 | 0.8% | 0.0 |
| SLP285 (L) | 2 | Glu | 2 | 0.8% | 0.0 |
| VES034_b (L) | 2 | GABA | 2 | 0.8% | 0.0 |
| SLP457 (L) | 2 | unc | 2 | 0.8% | 0.0 |
| AVLP220 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| AVLP457 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| AVLP447 (L) | 1 | GABA | 1 | 0.4% | 0.0 |
| AVLP302 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| SLP152 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| CRE088 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| SMP142 (L) | 1 | unc | 1 | 0.4% | 0.0 |
| AVLP345_a (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| AVLP595 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| SLP381 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| AVLP284 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| LHAD2e3 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| LHPV5b2 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| SMP357 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| LHPV4h1 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| CL271 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| SLP036 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| CL272_b1 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| CB1899 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| SLP122 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| CL136 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| CB4117 (L) | 1 | GABA | 1 | 0.4% | 0.0 |
| AVLP187 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| CL360 (L) | 1 | unc | 1 | 0.4% | 0.0 |
| AVLP028 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| VES037 (L) | 1 | GABA | 1 | 0.4% | 0.0 |
| M_vPNml60 (L) | 1 | GABA | 1 | 0.4% | 0.0 |
| LHPV2a1_c (L) | 1 | GABA | 1 | 0.4% | 0.0 |
| PLP085 (L) | 1 | GABA | 1 | 0.4% | 0.0 |
| LHCENT13_a (L) | 1 | GABA | 1 | 0.4% | 0.0 |
| OA-ASM2 (R) | 1 | unc | 1 | 0.4% | 0.0 |
| SLP248 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| SMP245 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| LHAV2k6 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| LHPV2a1_e (L) | 1 | GABA | 1 | 0.4% | 0.0 |
| AVLP446 (L) | 1 | GABA | 1 | 0.4% | 0.0 |
| GNG640 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| VP3+VP1l_ivPN (R) | 1 | ACh | 1 | 0.4% | 0.0 |
| M_ilPNm90 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| SMP503 (L) | 1 | unc | 1 | 0.4% | 0.0 |
| SLP057 (L) | 1 | GABA | 1 | 0.4% | 0.0 |
| AVLP475_a (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| CRE080_c (R) | 1 | ACh | 1 | 0.4% | 0.0 |
| LHCENT8 (L) | 1 | GABA | 1 | 0.4% | 0.0 |
| PLP015 (L) | 1 | GABA | 1 | 0.4% | 0.0 |
| OA-VUMa2 (M) | 1 | OA | 1 | 0.4% | 0.0 |
| PPL201 (L) | 1 | DA | 1 | 0.4% | 0.0 |
| AVLP433_a (R) | 1 | ACh | 1 | 0.4% | 0.0 |
| OA-VUMa8 (M) | 1 | OA | 1 | 0.4% | 0.0 |
| OA-VPM3 (R) | 1 | OA | 1 | 0.4% | 0.0 |
| OA-VUMa6 (M) | 1 | OA | 1 | 0.4% | 0.0 |
| downstream partner | # | NT | conns SLP307 | % Out | CV |
|---|---|---|---|---|---|
| SLP057 (L) | 1 | GABA | 28 | 5.7% | 0.0 |
| CB2659 (L) | 3 | ACh | 28 | 5.7% | 0.7 |
| SLP056 (L) | 1 | GABA | 26 | 5.3% | 0.0 |
| LHPV2a1_d (L) | 2 | GABA | 21 | 4.3% | 0.0 |
| SMP159 (L) | 1 | Glu | 20 | 4.1% | 0.0 |
| SMP315 (L) | 3 | ACh | 18 | 3.7% | 0.5 |
| SLP457 (L) | 2 | unc | 15 | 3.1% | 0.2 |
| SMP043 (L) | 2 | Glu | 11 | 2.2% | 0.3 |
| CL142 (L) | 1 | Glu | 9 | 1.8% | 0.0 |
| PPL201 (L) | 1 | DA | 9 | 1.8% | 0.0 |
| LHCENT13_b (L) | 2 | GABA | 8 | 1.6% | 0.8 |
| LHCENT13_a (L) | 2 | GABA | 8 | 1.6% | 0.0 |
| SLP003 (L) | 1 | GABA | 7 | 1.4% | 0.0 |
| CL272_a1 (L) | 1 | ACh | 7 | 1.4% | 0.0 |
| AVLP220 (L) | 2 | ACh | 7 | 1.4% | 0.4 |
| SLP438 (L) | 2 | unc | 7 | 1.4% | 0.1 |
| SLP012 (L) | 3 | Glu | 7 | 1.4% | 0.4 |
| AVLP166 (L) | 1 | ACh | 6 | 1.2% | 0.0 |
| SMP357 (L) | 1 | ACh | 5 | 1.0% | 0.0 |
| LHCENT3 (L) | 1 | GABA | 5 | 1.0% | 0.0 |
| SLP160 (L) | 2 | ACh | 5 | 1.0% | 0.2 |
| CL126 (L) | 1 | Glu | 4 | 0.8% | 0.0 |
| SLP209 (L) | 1 | GABA | 4 | 0.8% | 0.0 |
| SMP102 (L) | 1 | Glu | 4 | 0.8% | 0.0 |
| LHAV1f1 (L) | 1 | ACh | 4 | 0.8% | 0.0 |
| SLP472 (L) | 1 | ACh | 4 | 0.8% | 0.0 |
| CL360 (R) | 1 | unc | 4 | 0.8% | 0.0 |
| LHPV3c1 (L) | 1 | ACh | 4 | 0.8% | 0.0 |
| DNp43 (L) | 1 | ACh | 4 | 0.8% | 0.0 |
| AVLP215 (L) | 1 | GABA | 4 | 0.8% | 0.0 |
| AVLP597 (L) | 1 | GABA | 4 | 0.8% | 0.0 |
| LHPV2c5 (L) | 3 | unc | 4 | 0.8% | 0.4 |
| LHPV2a1_e (L) | 2 | GABA | 4 | 0.8% | 0.0 |
| PLP130 (L) | 1 | ACh | 3 | 0.6% | 0.0 |
| AVLP308 (L) | 1 | ACh | 3 | 0.6% | 0.0 |
| CB1140 (L) | 1 | ACh | 3 | 0.6% | 0.0 |
| AVLP038 (L) | 1 | ACh | 3 | 0.6% | 0.0 |
| CL256 (L) | 1 | ACh | 3 | 0.6% | 0.0 |
| CL231 (L) | 1 | Glu | 3 | 0.6% | 0.0 |
| CB1590 (L) | 1 | Glu | 3 | 0.6% | 0.0 |
| LHCENT13_d (L) | 1 | GABA | 3 | 0.6% | 0.0 |
| LHPV2e1_a (L) | 1 | GABA | 3 | 0.6% | 0.0 |
| CB3907 (L) | 1 | ACh | 3 | 0.6% | 0.0 |
| AVLP164 (L) | 1 | ACh | 3 | 0.6% | 0.0 |
| CL129 (L) | 1 | ACh | 3 | 0.6% | 0.0 |
| LHAD1f3_a (L) | 1 | Glu | 3 | 0.6% | 0.0 |
| CB3908 (L) | 1 | ACh | 3 | 0.6% | 0.0 |
| CB2689 (L) | 1 | ACh | 3 | 0.6% | 0.0 |
| CL021 (L) | 1 | ACh | 3 | 0.6% | 0.0 |
| ALIN1 (L) | 1 | unc | 3 | 0.6% | 0.0 |
| CL257 (L) | 1 | ACh | 3 | 0.6% | 0.0 |
| LHAV5c1 (L) | 2 | ACh | 3 | 0.6% | 0.3 |
| CL246 (L) | 1 | GABA | 2 | 0.4% | 0.0 |
| AOTU009 (L) | 1 | Glu | 2 | 0.4% | 0.0 |
| SMP342 (L) | 1 | Glu | 2 | 0.4% | 0.0 |
| PLP002 (L) | 1 | GABA | 2 | 0.4% | 0.0 |
| CL032 (L) | 1 | Glu | 2 | 0.4% | 0.0 |
| AVLP302 (L) | 1 | ACh | 2 | 0.4% | 0.0 |
| LHPV9b1 (L) | 1 | Glu | 2 | 0.4% | 0.0 |
| LHAD1f3_b (L) | 1 | Glu | 2 | 0.4% | 0.0 |
| PLP144 (L) | 1 | GABA | 2 | 0.4% | 0.0 |
| CB2281 (L) | 1 | ACh | 2 | 0.4% | 0.0 |
| LHAD2e3 (L) | 1 | ACh | 2 | 0.4% | 0.0 |
| CL272_b1 (L) | 1 | ACh | 2 | 0.4% | 0.0 |
| CB2952 (L) | 1 | Glu | 2 | 0.4% | 0.0 |
| SMP317 (L) | 1 | ACh | 2 | 0.4% | 0.0 |
| LHAV2b1 (L) | 1 | ACh | 2 | 0.4% | 0.0 |
| SMP361 (L) | 1 | ACh | 2 | 0.4% | 0.0 |
| CB2172 (L) | 1 | ACh | 2 | 0.4% | 0.0 |
| IB059_a (L) | 1 | Glu | 2 | 0.4% | 0.0 |
| LHAV3e1 (L) | 1 | ACh | 2 | 0.4% | 0.0 |
| SMP038 (L) | 1 | Glu | 2 | 0.4% | 0.0 |
| AVLP596 (L) | 1 | ACh | 2 | 0.4% | 0.0 |
| AVLP041 (L) | 1 | ACh | 2 | 0.4% | 0.0 |
| CL080 (L) | 1 | ACh | 2 | 0.4% | 0.0 |
| PLP095 (L) | 1 | ACh | 2 | 0.4% | 0.0 |
| M_smPNm1 (R) | 1 | GABA | 2 | 0.4% | 0.0 |
| SMP245 (L) | 1 | ACh | 2 | 0.4% | 0.0 |
| AVLP345_b (L) | 1 | ACh | 2 | 0.4% | 0.0 |
| SLP469 (L) | 1 | GABA | 2 | 0.4% | 0.0 |
| PLP257 (L) | 1 | GABA | 2 | 0.4% | 0.0 |
| AVLP315 (L) | 1 | ACh | 2 | 0.4% | 0.0 |
| WEDPN4 (L) | 1 | GABA | 2 | 0.4% | 0.0 |
| CL110 (L) | 1 | ACh | 2 | 0.4% | 0.0 |
| DNp29 (L) | 1 | unc | 2 | 0.4% | 0.0 |
| OA-VUMa6 (M) | 1 | OA | 2 | 0.4% | 0.0 |
| PLP086 (L) | 2 | GABA | 2 | 0.4% | 0.0 |
| SLP119 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| SLP103 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| SLP230 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| SMP503 (R) | 1 | unc | 1 | 0.2% | 0.0 |
| CB1899 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| SLP215 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| SLP072 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| SLP328 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| AVLP433_b (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LH008m (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| SLP381 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| SLP321 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| AVLP284 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| CB3414 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| CB2530 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| LHPD2a6 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| LHAV6c1 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| CB2185 (L) | 1 | unc | 1 | 0.2% | 0.0 |
| CB3496 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LHPD2c2 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| SLP158 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| SIP049 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| CL081 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| CL272_b3 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| CB3261 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| CB3255 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| SLP007 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| CL271 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| PVLP008_c (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| SMP248_c (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| SLP188 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| SMP447 (R) | 1 | Glu | 1 | 0.2% | 0.0 |
| CB1523 (R) | 1 | Glu | 1 | 0.2% | 0.0 |
| LHAV2g1 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| SLP421 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LHPV2a1_a (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| CL250 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| AVLP044_b (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| SIP076 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| CL359 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| OA-ASM2 (R) | 1 | unc | 1 | 0.2% | 0.0 |
| LH007m (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| CL099 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| AVLP037 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LHAV6e1 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| SMP255 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| AVLP163 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| AVLP432 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| PLP096 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| CL027 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| AVLP343 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| AVLP593 (L) | 1 | unc | 1 | 0.2% | 0.0 |
| LHPD4c1 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LHCENT4 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| SLP130 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LoVP109 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| CL092 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| AL-MBDL1 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
